indivior - our vision hero

Invest in People

Opioid use disorder is a disease that can happen to any of us. It's possible, recovery can happen to any of us too.

About Us

Annual Report and Accounts 2023

Our Annual Report and Accounts 2023 is available to download

indivior-nasdaq

Indivior's Nasdaq Listing and Campaign

Latest News

June 18 2024

Indivior Announces the Publication of New Data on the Comparative Effectiveness of Intranasal (IN) Nalmefene (OPVEE 2.7mg) and IN Naloxone (4 mg) in a Translational Model Assessing the Impact of a Synthetic Opioid Overdose on Respiratory Depression and Cardiac Arrest

Read more

Latest Results

June 5 2024

2024 Jefferies Global Healthcare Conference

Read more
indivior - careers

Careers

Accelerate your career by making a difference

Read more
indivior - r&d activities

Our R&D Activities

Driving development in addressing addiction and behavioural health issues

Read more
indivior - news and media

News And Media

The latest information on Indivior

Read more